Last reviewed · How we verify
NCT06793384: VR-CST-PwDVI
Virtual Reality in Cognitive Stimulation Therapy for Visually Impaired Older Individuals with Dementia
NA trial testing Virtual reality based Cognitive Stimulation Therapy (VR-CST) in Dementia Patients in 31 participants. Completed in 31 May 2020.
28 February 2020
Quick facts
| Lead sponsor | The Hong Kong Polytechnic University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 31 |
| Start date | 1 September 2019 |
| Primary completion | 28 February 2020 |
| Estimated completion | 31 May 2020 |
| Sites | 1 location across Hong Kong |
Drugs / interventions tested
- Virtual reality based Cognitive Stimulation Therapy (VR-CST)
- Conventional Cognitive Stimulation Therapy (Conventional CST)
Conditions studied
- Dementia Patients — all drugs for Dementia Patients →
Sponsor
The Hong Kong Polytechnic University
Who can join
60 and older, any sex, with Dementia Patients. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Both visual impairment and dementia are prevalent in the elderly population. Cognitive stimulation therapy (CST) is an evidence-based intervention for people with mild-to-moderate dementia. Virtual reality (VR) has been used in cognitive rehabilitation. However, the efficacy of CST and the feasibility of incorporating VR into therapy targeting people with dementia and visual impairment (PwDVI) have rarely been explored. The current pilot study addressed two issues: 1) To study the efficacy of conventional CST on PwDVI in different cognitive domains and 2) To explore the feasibility and efficacy of VR-CST on PwDVI in various cognitive domains.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Applying Cognitive Stimulation Therapy (CST) on People with Concurrent Visual Impairment and Dementia: A Preliminary Study
Tsang H, Luk C, Lo Y, Chiu A, et al · · 2026
Verify or expand the search:
- PubMed search for NCT06793384
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other The Hong Kong Polytechnic University trials
Trials by the same sponsor.
- NCT07505732 — Information-providing Chatbot · NA · not yet recruiting
- NCT07391449 — Heart Rate Variability Guided Physical Activity and Exercise Prescription in Individuals With Knee Osteoarthritis · NA · not yet recruiting
- NCT07450248 — The Use of Telephone-based ACT for Quitting Alcohol in the Young Population With Hazardous or Harmful Alcohol Use. · NA · not yet recruiting
- NCT07273682 — Nurse-led Transitional Care to Improve Symptom Management in Childhood Cancer Survivors · NA · not yet recruiting
- NCT07531082 — Effects of a Salutogenic Strength-based Social Robot-assisted Intervention on the Depressive Symptoms and Sense of Coher · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06793384 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The Hong Kong Polytechnic University
- Last refreshed: 27 January 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06793384.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing